Genomics BioSci & Tech. Co.,Ltd. (TPEX:4195)
Taiwan · Delayed Price · Currency is TWD 26.30
-0.55 (-2.05%)
Sep 17, 2025, 1:55 PM CST
Genomics BioSci & Tech. Revenue
Genomics BioSci & Tech. had revenue of 310.31M TWD in the half year ending June 30, 2025, with 61.88% growth. This brings the company's revenue in the last twelve months to 563.09M, up 29.62% year-over-year. In the year 2024, Genomics BioSci & Tech. had annual revenue of 482.75M with 21.86% growth.
Revenue (ttm)
563.09M
Revenue Growth
+29.62%
P/S Ratio
3.45
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.95B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 482.75M | 86.61M | 21.86% |
| Dec 31, 2023 | 396.14M | -22.86M | -5.46% |
| Dec 31, 2022 | 419.00M | 29.04M | 7.45% |
| Dec 31, 2021 | 389.97M | -53.21M | -12.01% |
| Dec 31, 2020 | 443.18M | 15.52M | 3.63% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Caliway Biopharmaceuticals | 44.83M |
| PharmaEssentia | 12.63B |
| Bora Pharmaceuticals Co., LTD. | 21.32B |
| Lumosa Therapeutics | 37.25M |
| Lotus Pharmaceutical | 19.12B |
| Oneness Biotech | 112.57M |
| Polaris Group | 64.02M |
| Center Laboratories | 1.60B |